← Open Payments lookup

SHARON PAIZ: Open Payments

NPI 1538846415 · MONTCLAIR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$794 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $712 · 2025 $794

Food & beverage: $794
CompanyPaymentsAmount
Novo Nordisk Inc10$258
Amgen Inc.12$151
Lilly USA, LLC4$98
Organon LLC2$43
PFIZER INC.2$42
Teva Pharmaceuticals USA, Inc.2$41
Astellas Pharma US Inc1$30
Janssen Pharmaceuticals, Inc1$29
Axsome Therapeutics, Inc.1$27
Bayer Healthcare Pharmaceuticals Inc.1$22

Products named: OTEZLA, Wegovy, MOUNJARO, NEXPLANON, PREVNAR 20, AUSTEDO XR, ZEPBOUND, Ozempic.

Industry payments across CA — which companies pay providers there.